Last updated at 05 Jul 2024 03:23 AM
Director
DIN: 00700517
Arush Sabharwal is currently associated with 3 companies in various capacities such as Director and Designated Partner. They serve as a Director at LEVANA IVF CENTER PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 00700517.Arush Sabharwal has previously been associated with 1 company in roles such as Director.Arush Sabharwal is currently involved in 2 different roles. Their most recent position is with MALVIN LIFESCIENCES PRIVATE LIMITED as a Director. The first company Arush Sabharwal was appointed to as a director was LEVANA IVF CENTER PRIVATE LIMITED. Arush Sabharwal is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Arush Sabharwal is currently associated with 3 companies in various capacities such as Director and Designated Partner. They serve as a Director at LEVANA IVF CENTER PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 00700517.Arush Sabharwal has previously been associated with 1 company in roles such as Director.Arush Sabharwal is currently involved in 2 different roles. Their most recent position is with MALVIN LIFESCIENCES PRIVATE LIMITED as a Director. The first company Arush Sabharwal was appointed to as a director was LEVANA IVF CENTER PRIVATE LIMITED. Arush Sabharwal is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (1)
Past Companies (1)
4y 5m 2y 3m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| LEVANA IVF CENTER PRIVATE LIMITED | Director | 20-Dec-2011 |
| MALVIN LIFESCIENCES PRIVATE LIMITED | Director | 06-Jan-2023 |